Roche invests 1.2 billion in research and production in Basel
Published: Friday, Nov 17th 2023, 10:40
Volver a Live Feed
The pharmaceutical company Roche wants to renew the infrastructure at its Basel site. Over the next two years, 1.2 billion Swiss francs are to be invested in a further research and development building.
The funds will also be used to renew the production facilities for synthetic chemical molecules and for a building for the Institute of Human Biology, as Roche announced on Friday. This investment is a commitment and an important step for the future of the Basel site.
Half a billion will be spent on the research and development building, which will have 13 floors and be 72 meters high. Over half a billion Swiss francs will be spent on the new production building and around 100 million on the Institute of Human Biology.
©Keystone/SDA
Spanish 
English 
German 
French 
Arabic